A significant percentage of chronic kidney disease cases remain undiagnosed, particularly in low-income countries, highlighting the need for routine urine testing.
New Delhi, India Jul 16, 2026 ALN: An estimated 30% to 50% of chronic kidney disease (CKD) cases remain undiagnosed even in high-income countries, with the proportion likely to be much higher in low- and middle-income nations, according to a new series of papers published in The Lancet. Researchers have urged wider use of simple urine tests to improve early diagnosis and treatment of a disease that affects 844 million adults worldwide.
Chronic kidney disease is a progressive condition characterized by the gradual loss of kidney function. The kidneys play a vital role in filtering waste products from the blood, regulating blood pressure, and maintaining electrolyte balance. As CKD progresses, it can lead to kidney failure, requiring either dialysis or a kidney transplant for survival. Currently, CKD is the ninth leading cause of death globally and is projected to ascend to the fifth position by 2040, according to the findings presented in the papers.
The researchers noted that CKD often progresses silently, with most individuals experiencing few or no symptoms until the disease reaches an advanced stage. This insidious nature of CKD contributes significantly to low diagnosis rates and delays in treatment, which can have dire consequences for patients. By the time symptoms manifest, such as fatigue, swelling, or changes in urination, the kidneys may have already sustained substantial damage.
The series, led by researchers from the University of Glasgow, emphasized the importance of routine urine testing for protein, which is a key indicator of kidney damage. Along with blood tests that measure kidney function and regular blood pressure checks, these methods could facilitate the early detection of CKD. Early diagnosis is crucial as it allows for timely interventions that can slow or even halt the progression of the disease, potentially averting the need for more invasive treatments such as dialysis.
Moreover, the papers highlighted significant disparities in CKD diagnosis, noting that women and individuals from non-white ethnic groups are more likely to remain undiagnosed. This raises concerns about health equity and the need for targeted screening efforts to ensure that vulnerable populations receive adequate care. Even among patients whose medical records indicate the presence of CKD, many remain unaware of their condition, underscoring the necessity for improved patient education and outreach.
Researchers identified several leading risk factors for CKD, including diabetes, hypertension, obesity, and cardiovascular disease. The risk of developing CKD also increases with age, making it a growing concern as populations around the world age. As the prevalence of these risk factors continues to rise, particularly in the context of increasing rates of obesity and sedentary lifestyles, the burden of CKD is expected to escalate further.
The authors of the study called for greater investment in kidney disease screening, laboratory capacity, and healthcare systems, particularly in low- and middle-income countries where access to diagnostic services remains limited. In many of these regions, healthcare infrastructure is underdeveloped, and there is often a lack of trained healthcare professionals capable of performing necessary tests or interpreting results. This can lead to significant delays in diagnosis and treatment, exacerbating health disparities.
In addition to calling for improved screening, the series reviewed advancements in kidney disease research, including the development of improved biomarkers that can more accurately indicate kidney damage and function. Genetic testing is also emerging as a valuable tool in understanding individual risk factors for CKD, paving the way for personalized medicine approaches in treatment. Newer therapies that can delay disease progression when treatment is initiated early have shown promise in clinical trials, offering hope for better outcomes for patients.
The implications of these findings are significant. As CKD continues to be a leading cause of morbidity and mortality worldwide, addressing the gaps in diagnosis and treatment is essential for improving public health outcomes. By advocating for routine screening and increased investment in healthcare resources, researchers aim to not only reduce the burden of CKD but also enhance the quality of life for millions of individuals affected by this silent disease.
Furthermore, policymakers are urged to consider the economic impact of CKD, as untreated kidney disease can lead to increased healthcare costs associated with advanced treatments, hospitalizations, and lost productivity due to illness. By prioritizing early detection and intervention, healthcare systems can potentially save substantial resources while improving patient outcomes.
Global health initiatives have increasingly focused on addressing non-communicable diseases (NCDs), including CKD, particularly in low- and middle-income countries. Organizations such as the World Health Organization (WHO) have recognized the need for comprehensive strategies that include prevention, early diagnosis, and management of chronic diseases. These strategies often involve multi-sectoral collaboration, integrating health systems with community engagement to ensure that at-risk populations are reached.
In many regions, public health campaigns aimed at raising awareness about CKD risk factors, such as diabetes and hypertension, have been implemented. These campaigns often emphasize lifestyle modifications, including dietary changes, increased physical activity, and regular health check-ups, which are crucial in managing risk factors that contribute to CKD development.
Looking ahead, the integration of technology in healthcare, such as telemedicine and mobile health applications, presents new opportunities for improving CKD screening and management. These technologies can facilitate remote monitoring and provide patients with access to healthcare professionals without the need for in-person visits, which can be particularly beneficial in rural or underserved areas. Such innovations may help bridge the gap in healthcare access and improve early diagnosis rates.
Moreover, the ongoing research into genetic predispositions for CKD could lead to more targeted prevention strategies. Understanding the genetic basis of kidney disease may allow healthcare providers to identify at-risk individuals earlier and implement preventative measures tailored to their specific risk profiles.
In summary, the series published in The Lancet sheds light on the pressing issue of undiagnosed chronic kidney disease and highlights the need for systematic changes in how we approach kidney health. With appropriate screening measures, increased public awareness, and investment in healthcare infrastructure, it is possible to make significant strides in the fight against CKD and improve the lives of millions worldwide. The call for action is clear: enhancing early detection and treatment can not only save lives but also reduce the economic burden associated with advanced kidney disease, making it a priority for global health agendas.
To learn more about the latest developments in Health News, stay updated with our exclusive reports and analyses on AiLensNews.
